Get started
Author

Yu Kochi

Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma
2019 · Tatsushi Kodama, Yu Kochi, et al. · Molecular Cancer Therapeutics · 85
Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function
2022 · Yoshikane Kikushige, Toshihiro Miyamoto, et al. · Blood Advances · 34
PDF
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells
2025 · Gentaro Kawano, Riichiro Ikeda, et al. · Blood · 9
PDF
GPAM mediated lysophosphatidic acid synthesis regulates mitochondrial dynamics in acute myeloid leukemia
2023 · Hidetoshi Irifune, Yu Kochi, et al. · Cancer Science · 9
PDF
Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules
2017 · Tsuyoshi Muta, Tomoyasu Yoshihiro, et al. · Internal Medicine · 9
PDF
Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RARα
2025 · Mariko Minami, Teppei Sakoda, et al. · Leukemia · 7
CPSF1 Regulates AML1-ETO Fusion Gene Polyadenylation and Stability in t(8;21) Acute Myelogenous Leukemia
2017 · Takahiro Shima, Amanda G Davis, et al. · Blood · 2
Procalcitonin elevation in febrile recipients during pre-transplant conditioning with anti-thymocyte globulin
2024 · Takahiro Shima, Mariko Minami, et al. · BLOOD CELL THERAPY / The official journal of APBMT · 1
PDF
Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation
2022 · Shiho Taniguchi, Sae Utsumi, et al. · International Journal of Hematology · 1
CPSF1-Mediated Acute Myeloid Leukemia Fusion 3'UTR Alternation Is a Potential Therapeutic Target
2018 · Takahiro Shima, Amanda G Davis, et al. · Blood · 1
Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis
2018 · Tatsuji Mino, Yuta Katayama, et al. · Blood · 1
Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for PJP prophylaxis after allogeneic hematopoietic cell transplantation: Association with bacterial infections and survival
2026 · Takashi Jiromaru, Yasuo Mori, et al. · Journal of Infection and Chemotherapy
[Successful intensive treatment for severe fever with thrombocytopenia syndrome complicated by virus-associated hemophagocytic syndrome in a very elderly patient].
2025 · Riichiro Ikeda, Yu Kochi, et al. · PubMed
A case of Schnitzler syndrome complicated by rheumatoid arthritis treated with methotrexate
2025 · Kensuke Irino, Yu Kochi, et al. · Modern Rheumatology Case Reports
Data from Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma
2023 · Tatsushi Kodama, Yu Kochi, et al.
Data from Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma
2023 · Tatsushi Kodama, Yu Kochi, et al.
Supplementary Tables S1-S2 from Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma
2023 · Tatsushi Kodama, Yu Kochi, et al.
Supplementary Figures S1-S7 from Anti-GPRC5D/CD3 Bispecific T-Cell–Redirecting Antibody for the Treatment of Multiple Myeloma
2023 · Tatsushi Kodama, Yu Kochi, et al.
Suppressed Expression of ASCT1 Contributes to the Maintenance of Leukemia Stemness Via the Enhancement of Antioxidant Capacity
2022 · Yu Kochi, Yoshikane Kikushige, et al. · Blood
Abstract 1886: Anti -GPRC5D/CD3 T cell-redirecting bispecific antibody with potent in vitro and in vivo antitumor efficacy against multiple myeloma
2021 · Tatsushi Kodama, Yu Kochi, et al. · Cancer Research
Identification of GPAT1 As a Novel Therapeutic Target for Acute Leukemia By Inhibiting Leukemia Specific Metabolism
2019 · Hidetoshi Irifune, Yu Kochi, et al. · Blood
Significance of Soluble Interleukin-2 Receptor to Predict Prognosis and Support Decision-Making on Watchful Waiting for Stage II-IV Follicular Lymphoma Patients in the Rituximab Era
2018 · Tsuyoshi Muta, Takeshi Okatani, et al. · Blood
ASCT1 contributes to survival of aerobic AML cells through enhancement of antioxidant activity
2018 · Yu Kochi · The Japanese Society of Hematology
Identification of ASCT1 As a Candidate Molecule Enhancing Antioxidant Activity in Primary Human AML Cells
2016 · Yu Kochi, Yoshikane Kikushige, et al. · Blood
Works count: 24
Citation count: 159
H-index: 6
I10-index: 2
Year
Topic
Type